Opinion: The Pandemic and the RNA Sequencing Gap

RNA sequencing technology lags far behind researchers’ ability to decode and understand DNA. The COVID-19 pandemic has highlighted this dangerous shortcoming.

Written byRobert Ross
| 3 min read
Image of the microscopic view of an infectious virus cell, RNA.

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: © ISTOCK.COM, CROCOTHERY

The worldwide attention on the SARS-CoV-2 virus has emphasized the dearth of analytical methodologies for rapid and cost-effective identification and characterization of viral RNA. Many virus families, including pathogenic varieties such as coronaviruses, human retroviruses, and influenza, are RNA viruses, meaning their genetic material occurs in the form of RNA instead of DNA. When these viruses infect host cells, the viral RNA package hijacks the infected cell’s molecular machinery and begins producing its own viral molecules, which eventually overwhelm the cell, releasing new viral molecules to infect other cells in the system.

Almost 20 years ago, an RNA virus now known as SARS-CoV-1 spread through the human population killing nearly 775 people who suffered from the severe acute respiratory syndrome (SARS) that the virus caused. Since 2012, Middle East respiratory syndrome (MERS), another disease caused by an RNA coronavirus, has killed more than 850 people, approximately ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Online only cover of the The Scientist, September 2021 issue
September 2021

Mapping Covid

SARS-COV-2 wreaks havoc around the body

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery